Pro-Dex Inc New

PDEX

Pro-Dex Inc (PDEX) is a company specializing in the design, development, and manufacturing of surgical drills and other precision instruments primarily used in the medical device industry. The firm provides innovative, high-quality products aimed at improving surgical procedures, with a focus on dental, neurosurgery, and other specialized medical applications.

$39.88 -0.54 (-1.34%)
🚫 Pro-Dex Inc New does not pay dividends

Company News

The Zacks Analyst Blog Highlights Toyota Motor, Lockheed Martin, Chubb and Pro-Dex
Zacks Investment Research • Zacks.Com • August 1, 2024

The article highlights the performance and outlook of Toyota Motor, Lockheed Martin, Chubb, and Pro-Dex. It discusses the companies' strengths, challenges, and growth strategies.

70 Biggest Movers From Friday
Benzinga • Lisa Levin • May 10, 2021

Gainers InnSuites Hospitality Trust (NYSE: IHT) shares gained 43.4% to close at $3.50 on Friday. Velocity Financial, Inc. (NYSE: VEL) rose 36.6% to close at $12.50 following Q1 earnings. Yield10 Bioscience, Inc. (NASDAQ: YTEN) jumped 26.2% to close at $10.83. The L.S. Starrett Company (NYSE: SCX) gained 26.2% to close at $7.85 after reporting hi...

Mid-Afternoon Market Update: Dow Surges Over 200 Points; ChemoCentryx Shares Drop
Benzinga • Lisa Levin • May 7, 2021

Toward the end of trading Friday, the Dow traded up 0.62% to 34,761.24 while the NASDAQ rose 0.95% to 13,762.12. The S&P also rose, gaining 0.74% to 4,232.81. The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 32,605,480 cases with around 580,060 deaths. India confirmed a total of at least 21,491,59...

12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga • Benzinga Insights • May 7, 2021

Gainers Yield10 Bioscience (NASDAQ:YTEN) stock increased by 20.74% to $10.36 during Friday's regular session. As of 12:30 EST, Yield10 Bioscience's stock is trading at a volume of 119.1K, which is 125.67% of its average full-day volume over the last 100 days. The company's market cap stands at $50.4 million. Epizyme (NASDAQ:EPZM) stock rose 20.6...

Mid-Day Market Update: Pro-Dex Rises After Q3 Results; Orphazyme Shares Slide
Benzinga • Lisa Levin • May 7, 2021

Midway through trading Friday, the Dow traded up 0.45% to 34,705.48 while the NASDAQ rose 1.35% to 13,816.46. The S&P also rose, gaining 0.77% to 4,233.93. The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 32,605,480 cases with around 580,060 deaths. India confirmed a total of at least 21,491,590 c...

Related Companies